AJR F and L Medical Products: Radiation Protection & More
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schulte, A.-C.
Right arrow Articles by Bilecen, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schulte, A.-C.
Right arrow Articles by Bilecen, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2005; 185:735-740
© American Roentgen Ray Society


Clinical Observations

Intraarterial Versus IV Gadolinium Injections for MR Angiography: Quantitative and Qualitative Assessment of the Infrainguinal Arteries

Anja-Carina Schulte1, Georg Bongartz2, Rolf Huegli2, Markus Aschwanden3, Kurt A. Jaeger3, Wladimir Ostheim-Dzerowycz4, Augustinus L. Jacob2 and Deniz Bilecen2

1 Biocenter, University of Basel, Basel, Switzerland.
2 Institute of Diagnostic Radiology, University Hospital of Basel, Petersgraben 4, Basel, Switzerland 4031.
3 Department of Angiology, University Hospital of Basel, Basel, Switzerland.
4 Hochrheinklinik, Bad Saeckingen, Germany.

OBJECTIVE. Our purpose was to quantitatively and qualitatively compare 3D intraarterial (IA) gadolinium-enhanced MR angiography (IA MRA) versus the standard of reference of MR angiography, 3D IV gadolinium-enhanced MR angiography (IV MRA), in patients with peripheral arterial occlusive disease (PAOD) for use during catheter-based MR-guided endovascular interventions.

CONCLUSION. IA MRA provides image quality of the infrainguinal arteries in PAOD patients comparable to IV MRA with a significantly improved assessment of the infrapopliteal arteries due to reduced venous contamination. Further benefits of IA MRA include usage of only very low doses of gadolinium and simplified bolus timing.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
F. Poschenrieder, O. W. Hamer, T. Herold, T. Schleicher, I. Borisch, S. Feuerbach, and N. Zorger
Diagnostic Accuracy of Intraarterial and IV MR Angiography for the Detection of Stenoses of the Infrainguinal Arteries
Am. J. Roentgenol., January 1, 2009; 192(1): 117 - 121.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. Potthast, G. M. Bongartz, R. Huegli, A.-C. Schulte, J. G. Schwarz, M. Aschwanden, and D. Bilecen
Intraarterial Contrast-Enhanced MR Aortography With and Without Parallel Acquisition Technique in Patients with Peripheral Arterial Occlusive Disease
Am. J. Roentgenol., March 1, 2007; 188(3): 823 - 829.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Roentgen Ray Society.